SCHEMBL657401

SCHEMBL657401

CCCCCCCCCCC(CCCCCCCC)[C](CCCCCCCC)CCCCCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.48
FFAR4 Q5NUL3 2/20 0.47
FFAR1 O14842 2/20 0.47
LMNA P02545 1/20 0.46
CES2 O00748 3/20 0.44
CES1 P23141 3/20 0.44
GRIK1 P39086 1/20 0.42
GRIK2 Q13002 1/20 0.42
GPR84 Q9NQS5 6/20 0.42
PPARG P37231 6/20 0.42
PPARD Q03181 6/20 0.42
PPARA Q07869 6/20 0.42
HDAC11 Q96DB2 5/20 0.42
TSHR P16473 4/20 0.42
ALDH1A1 P00352 2/20 0.42
TLR2 O60603 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
FABP4 P15090 2/20 0.42
PTPN1 P18031 2/20 0.42
SLC22A6 Q4U2R8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8008995 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL10519624 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL15019100 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL7511263 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL3307047 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL7666492 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL23498813 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL16209868 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL7767174 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2
SCHEMBL16702733 1.00 CA2 (0.48) CA2FFAR4FFAR1LMNACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2187859-A1 POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS Arizona Chemical Company (US) 2010-05-26 EP claimed
WO-2009039158-A1 POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS ARIZONA CHEMICAL COMPANY (US) 2009-03-26 WO claimed
US-20090074685-A1 POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS ARIZONA CHEMICAL COMPANY, LLC 2009-03-19 US claimed
US-20220105018-A1 ANTIMICROBIAL COMPOSITION SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-04-07 US disclosed
WO-2021102886-A1 COMPOSITION FOR CARING FOR/MAKING UP KERATAIN FIBERS L'OREAL (FR) 2021-06-03 WO disclosed
US-10246608-B2 Non-fluorinated urethane based coatings THE CHEMOURS COMPANY FC, LLC (US) 2019-04-02 US disclosed
US-10011617-B2 Isocyanate derived organosilanes THE CHEMOURS COMPANY FC, LLC (US) 2018-07-03 US disclosed
US-20160090392-A1 ISOCYANATE DERIVED ORGANOSILANES JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2016-03-31 US disclosed
US-20160090508-A1 NON-FLUORINATED URETHANE BASED COATINGS JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2016-03-31 US disclosed
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
US-8383160-B2 Compositions comprising solid particles entrapped in collapsed polymeric microspheres, and methods of making the same ELC MANAGEMENT, LLC (US) 2013-02-26 US disclosed
US-20120045579-A1 Compositions Comprising Solid Particles Entrapped in Collapsed Polymeric Microspheres, and Methods of Making the Same SOJKA MILAN F (US) 2012-02-23 US disclosed
WO-2010132410-A2 SOLID COSMETIC COMPOSITION WITH STRUCTURANT AND ELECTROLYTE SOLUTION POPOFF CHRISTINE (US) 2010-11-18 WO disclosed
EP-1962752-A2 ANTIMICROBIAL CELLULOSIC SHEET Georgia-Pacific Consumer Products LP (US) 2008-09-03 EP disclosed
US-20080139765-A1 Polymers having improved cosmetic wear properties SPIEGEL MICHAEL 2008-06-12 US disclosed
WO-2007097818-A2 ANTIMICROBIAL CELLULOSIC SHEET GEORGIA-PACIFIC CONSUMER PRODUCTS LP (US) 2007-08-30 WO disclosed
US-20060067960-A1 Color cosmetic compositions CITICORP USA, INC. 2006-03-30 US disclosed
US-6283018-B1 Method of embossing a web and cleaning deposits from embossing roll FORT JAMES CORPORATION 2001-09-04 US disclosed
US-6250902-B1 Embossing roll cleaning apparatus FORT JAMES CORPORATION 2001-06-26 US disclosed
US-6093256-A PREVENTING BUILD-UP OF DEPOSITS COLOR-BOX LLC, DELAWARE LIMITED LIABILITY COMPANY 2000-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160090392-A1 ISOCYANATE DERIVED ORGANOSILANES IDH3A, IDH2, IDH1 CA2 1143/4885FFAR4 3690/4885FFAR1 2819/4885
US-10011617-B2 Isocyanate derived organosilanes IDH3A, IDH2, IDH1 CA2 1143/4885FFAR4 3690/4885FFAR1 2819/4885
US-20080139765-A1 Polymers having improved cosmetic wear properties CUTA, TREH, CETP CA2 991/4885FFAR4 2045/4885FFAR1 2049/4885
US-20060067960-A1 Color cosmetic compositions MSH6, HMBS, TYR CA2 4227/4885FFAR4 1457/4885FFAR1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.